EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Updating understanding of real-world adverse events associated with omeprazole

Jijun Zhang, Jie An iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0330509 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Jijun Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China. Hauptthemen laut MEDLINE: Omeprazole, Proton Pump Inhibitors. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aims to assess the adverse events (AEs) and safety profile of omeprazole, a widely used proton pump inhibitor (PPI) for acid-related diseases. Despite being a first-line treatment, its overuse due to easy accessibility and lack of public awareness about usage guidelines may lead to potential side effects, necessitating a reassessment of its safety.

Methods

We extracted 119,159 adverse event reports (AERs) related to omeprazole from the FDA Adverse Event Reporting System (FAERS) database, covering data from Q1 2004 to Q4 2023. A disproportionality analysis was performed to evaluate indications, concomitant medication use, and safety.

Results

Omeprazole was commonly prescribed for gastroesophageal reflux disease (GERD), dyspepsia, peptic ulcers, and gastritis. It was frequently used with drugs like aspirin, lisinopril, furosemide, atorvastatin, and metoprolol. Notably, renal and urinary disorders showed strong positive signals, including chronic kidney disease, acute kidney injury, and renal failure, with statistically significant disproportionality measures. The study also identified adverse reactions not listed on drug labels, such as hyperparathyroidism secondary and intentional product misuse.

Conclusions

Our findings provide new insights into the safety of omeprazole in real-world clinical settings, highlighting novel adverse events and offering evidence for safer clinical use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OmeprazoleProton Pump InhibitorsHumansAdverse Drug Reaction Reporting SystemsMaleFemaleGastroesophageal RefluxUnited StatesMiddle AgedAdultPeptic UlcerAged

Substanzen

OmeprazoleProton Pump Inhibitors

Autor:innen und Institutionen

  • Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China.
  • Department of General Surgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China.

ORCID-Profile: Jie An

Zitieren

APA

Zhang, J., & An, J. (2025). Updating understanding of real-world adverse events associated with omeprazole. PLOS One. https://doi.org/10.1371/journal.pone.0330509

Vancouver

Zhang J, An J. Updating understanding of real-world adverse events associated with omeprazole. PLOS One. 2025. doi:10.1371/journal.pone.0330509

BibTeX
@article{Zhang2025,
  author = {Zhang, Jijun and An, Jie},
  title = {Updating understanding of real-world adverse events associated with omeprazole},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0330509}
}
Kostenlos starten →